Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 25 articles: HTML format Text format

Single Articles

June 2018
1. DE SEMIR D, Bezrookove V, Nosrati M, Dar AA, et al
   PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.
   Proc Natl Acad Sci U S A. 2018 Jun 4. pii: 1804779115.
   PubMed     Text format     Abstract available
   
   
   May 2018
2. LEITHNER K, Triebl A, Trotzmuller M, Hinteregger B, et al
   The glycerol backbone of phospholipids derives from noncarbohydrate precursors in starved lung cancer cells.
   Proc Natl Acad Sci U S A. 2018 May 29. pii: 1719871115.
   PubMed     Text format     Abstract available
   
   
   February 2018
3. 
   Correction for Goncalves et al., Fenofibrate prevents skeletal muscle loss in mice with lung cancer.
   Proc Natl Acad Sci U S A. 2018 Feb 20. pii: 1801372115.
   PubMed     Text format    
   
   
   January 2018
4. GONCALVES MD, Hwang SK, Pauli C, Murphy CJ, et al
   Fenofibrate prevents skeletal muscle loss in mice with lung cancer.
   Proc Natl Acad Sci U S A. 2018 Jan 8. pii: 1714703115.
   PubMed     Text format     Abstract available
   
   
   November 2017
5. YAO K, Peng C, Zhang Y, Zykova TA, et al
   RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth.
   Proc Natl Acad Sci U S A. 2017 Nov 13. pii: 201710756.
   PubMed     Text format     Abstract available
   
   
   June 2017
6. GOCHEVA V, Naba A, Bhutkar A, Guardia T, et al
   Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival.
   Proc Natl Acad Sci U S A. 2017 Jun 26. pii: 201707054.
   PubMed     Text format     Abstract available
   
   
   April 2017
7. KAMPHORST AO, Pillai RN, Yang S, Nasti TH, et al
   Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.
   Proc Natl Acad Sci U S A. 2017 Apr 26. pii: 201705327.
   PubMed     Text format     Abstract available
   
   
   
8. 
   Editorial Expression of Concern: WWOX gene restoration prevents lung cancer growth in vitro and in vivo.
   Proc Natl Acad Sci U S A. 2017 Apr 3. pii: 201704296.
   PubMed     Text format    
   
   
   March 2017
9. 
   Correction for Tang et al., High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.
   Proc Natl Acad Sci U S A. 2017 Mar 27. pii: 201703650.
   PubMed     Text format    
   
   
   
10. MOU H, Moore J, Malonia SK, Li Y, et al
    Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis.
    Proc Natl Acad Sci U S A. 2017 Mar 20. pii: 201620861.
    PubMed     Text format     Abstract available
    
    
    
11. 
    Correction for Jeon et al., A set of NF-kappaB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer.
    Proc Natl Acad Sci U S A. 2017 Mar 13. pii: 201701795.
    PubMed     Text format    
    
    
    February 2017
12. 
    Correction for Shrivastava et al., Global long-range transport and lung cancer risk from polycyclic aromatic hydrocarbons shielded by coatings of organic aerosol.
    Proc Natl Acad Sci U S A. 2017 Feb 27. pii: 201702221.
    PubMed     Text format    
    
    
    
13. TANG Y, Wang Z, Li Z, Kim J, et al
    High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.
    Proc Natl Acad Sci U S A. 2017 Feb 21. pii: 201612229.
    PubMed     Text format     Abstract available
    
    
    January 2017
14. SHRIVASTAVA M, Lou S, Zelenyuk A, Easter RC, et al
    Global long-range transport and lung cancer risk from polycyclic aromatic hydrocarbons shielded by coatings of organic aerosol.
    Proc Natl Acad Sci U S A. 2017 Jan 23. pii: 201618475.
    PubMed     Text format     Abstract available
    
    
    
15. TUNG B, Schade B, Cardiff RD, Aina OH, et al
    beta-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.
    Proc Natl Acad Sci U S A. 2017 Jan 17. pii: 201610383.
    PubMed     Text format     Abstract available
    
    
    
16. CHEN P, Zuo H, Xiong H, Kolar MJ, et al
    Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2017 Jan 3. pii: 201614035.
    PubMed     Text format     Abstract available
    
    
    November 2016
17. OKIMOTO RA, Lin L, Olivas V, Chan E, et al
    Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase BRAF-mutant lung cancer.
    Proc Natl Acad Sci U S A. 2016 Nov 9. pii: 201610456.
    PubMed     Text format     Abstract available
    
    
    September 2016
18. YAN Y, Liu L, Xiong H, Miller JB, et al
    Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cells.
    Proc Natl Acad Sci U S A. 2016 Sep 12. pii: 201606886.
    PubMed     Text format     Abstract available
    
    
    June 2016
19. DAI YB, Miao YF, Wu WF, Li Y, et al
    Ablation of Liver X receptors alpha and beta leads to spontaneous peripheral squamous cell lung cancer in mice.
    Proc Natl Acad Sci U S A. 2016 Jun 22. pii: 201607590.
    PubMed     Text format     Abstract available
    
    
    
20. KUDINOV AE, Deneka A, Nikonova AS, Beck TN, et al
    Musashi-2 (MSI2) supports TGF-beta signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis.
    Proc Natl Acad Sci U S A. 2016 Jun 6. pii: 201513616.
    PubMed     Text format     Abstract available
    
    
    February 2016
21. TRIPATHI SC, Peters HL, Taguchi A, Katayama H, et al
    Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.
    Proc Natl Acad Sci U S A. 2016 Feb 29. pii: 201521812.
    PubMed     Text format     Abstract available
    
    
    
22. SUBBIAH V, Hong DS, Meric-Bernstam F
    Clinical activity of ceritinib in ROS1-rearranged non-small cell lung cancer: Bench to bedside report.
    Proc Natl Acad Sci U S A. 2016 Feb 25. pii: 201522052.
    PubMed     Text format    
    
    
    January 2016
23. OZTURK S, Papageorgis P, Wong CK, Lambert AW, et al
    SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis.
    Proc Natl Acad Sci U S A. 2016 Jan 6. pii: 201514663.
    PubMed     Text format     Abstract available
    
    
    November 2015
24. YEDDULA N, Xia Y, Ke E, Beumer J, et al
    Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma.
    Proc Natl Acad Sci U S A. 2015;112:E6476-85.
    PubMed     Text format     Abstract available
    
    
    September 2015
25. DAVARE MA, Vellore NA, Wagner JP, Eide CA, et al
    Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors.
    Proc Natl Acad Sci U S A. 2015;112:E5381-90.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: